1. Home
  2. HUMA vs INGN Comparison

HUMA vs INGN Comparison

Compare HUMA & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc.

HUMA

Humacyte Inc.

N/A

Current Price

$1.20

Market Cap

182.6M

Sector

Health Care

ML Signal

N/A

Logo Inogen Inc

INGN

Inogen Inc

N/A

Current Price

$6.39

Market Cap

156.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUMA
INGN
Founded
2004
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
182.6M
156.1M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
HUMA
INGN
Price
$1.20
$6.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
3
Target Price
$10.00
$11.00
AVG Volume (30 Days)
5.9M
336.2K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.42
EPS
N/A
N/A
Revenue
N/A
$348,668,000.00
Revenue This Year
N/A
$7.92
Revenue Next Year
$731.05
$7.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.86
52 Week Low
$0.88
$5.34
52 Week High
$3.35
$9.13

Technical Indicators

Market Signals
Indicator
HUMA
INGN
Relative Strength Index (RSI) 56.36 54.04
Support Level $0.92 $5.68
Resistance Level $1.26 $7.12
Average True Range (ATR) 0.09 0.40
MACD 0.00 0.07
Stochastic Oscillator 70.45 69.53

Price Performance

Historical Comparison
HUMA
INGN

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About INGN Inogen Inc

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

Share on Social Networks: